Please assess the completion status of the following clinical trial:

Trial Title: Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes according to WHO 1999 criteria for at least 3 month~* Insulin treated for at least 1 month~* BMI 25-40~* Age 18-80~* Hb1Ac \< 10%~Exclusion Criteria:~* Hypertension not well regulated~* Serum creatinine \> 130 micromol/l~* Non-diabetic kidney disease~* Disease that may cause invalid hgbA1c measurement~* Substance abuse~* Recent use of Detemir~* Pregnancy or risk of becoming pregnant~* Any condition that may disturb protocol adherence (language barrier etc) urinary albumin \> 30 mg/24hours ( before screening)~* Use of drugs that may influence blood glucose (except oral antidiabetics)~* Use of drugs that may influence sodium balance,i.e diuretics ( tiazides accepted)~* Clinical significant disease that may influence outcome ( cancer etc)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): 8 weeks of insulin Detemir, then cross over to 8 Weeks of Insulatard, then cross over to 1 week of Detemir
- 2 (Type: ACTIVE_COMPARATOR): 8 weeks of Insulin Insulatard, then cross over to 8 weeks of insulin Detemir, then crossover to 1 week of Insulin Insulatard

Based on this trial design, predict the completion outcome and termination type (if applicable).